Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Capital Employed (ROCE) | 14.6% | 16.2% | 18.9% | 20.2% | 25.3% | 28.9% | 23.7% | 18.6% | 13.5% | 15.9% | 7.8% | 8.7% | 10.2% | (0.9%) | 18.1% | 14.6% | 16.3% | 17.0% | 19.9% | 26.1% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Return on Capital Employed (ROCE) is 26.5%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Capital Employed (ROCE) for Eli Lilly and Company have been 18.8% over the past three years, and 18.9% over the past five years.
As of today, Eli Lilly and Company's Return on Capital Employed (ROCE) is 26.5%, which is higher than industry median of 12.8%. It indicates that Eli Lilly and Company's Return on Capital Employed (ROCE) is Good.